In recent years, an increasing number of studies have confirmed that HOXC6 is involved in many physiological and pathophysiological processes, such as those in nasopharyngeal carcinoma [7], gastric cancer [8], oesophageal squamous cell carcinoma [9], and prostate cancer [10]. Here, HOXC6 is linked to prostate cancer.